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g-glutamyl transpeptidase acivicin; ammonia production wasTissue engineering of a bioartificial renal tubule assist device:
present and incremented with declines in perfusion pH. Finally,In vitro transport and metabolic characteristics.
endocrinological activity with conversion of 25-hydroxy(OH)-Background. Current renal substitution therapy for acute
vitamin D3 to 1,25-(OH)2 vitD3 was demonstrated in the RAD.or chronic renal failure with hemodialysis or hemofiltration is
This conversion activity was up-regulated with parathyroid hor-life sustaining, but continues to have unacceptably high morbid-
mone and down-regulated with increasing inorganic phosphateity and mortality rates. This therapy is not complete renal
levels, which are well-defined physiological regulators of thisreplacement therapy because it does not provide active trans-
process in vivo.port nor metabolic and endocrinologic functions of the kidney,
Conclusions. These results clearly demonstrate the success-which are located predominantly in the tubular elements of
ful tissue engineering of a bioartificial RAD that possessesthe kidney.
critical differentiated transport, and improves metabolic andMethods. To optimize renal substitution therapy, a bioar-
endocrinological functions of the kidney. This device, whentificial renal tubule assist device (RAD) was developed and
placed in series with conventional hemofiltration therapy, maytested in vitro for a variety of differentiated tubular functions.
provide incremental renal replacement support and potentiallyHigh-flux hollow-fiber hemofiltration cartridges with mem-
may decrease the high morbidity and mortality rates observedbrane surface areas of 97 cm2 or 0.4 m2 were used as tubular
in patients with renal failure.scaffolds. Porcine renal proximal tubule cells were seeded into
the intraluminal spaces of the hollow fibers, which were pre-
treated with a synthetic extracellular matrix protein. Attached
cells were expanded in the cartridge as a bioreactor system to The rapid understanding of the cellular and molecularproduce confluent monolayers containing up to 1.5 3 109 cells
basis of organ function and disease will continue to be(3.5 3 105 cells/cm2). Near confluency was achieved along the
translated into new therapeutic approaches to a wideentire membrane surface, with recovery rates for perfused inu-
lin exceeding 97 and 95% in the smaller and larger units, respec- range of clinical disorders, including renal failure. The
tively, compared with less than 60% recovery in noncell units. translation of genetic engineering has already resulted
Results. A single-pass perfusion system was used to assess in the large-scale production and use of protein deriva-transport characteristics of the RADs. Vectorial fluid transport
tives for successful therapeutic compounds, such asfrom intraluminal space to antiluminal space was demonstrated
erythropoietin, in chronic renal disease [1]. The success-and was significantly increased with the addition of albumin
to the antiluminal side and inhibited by the addition of ouabain, ful translation of this strategy, however, has been limited
a specific inhibitor of Na1,K1-ATPase. Other transport activi- because many disease processes are not due to the lack
ties were also observed in these devices and included active of a single protein, but are caused by an alteration inbicarbonate transport, which was decreased with acetazolam-
complex interactions of a variety of cell products. Toide, a carbonic anhydrase inhibitor, active glucose transport,
develop a desired effect that is dependent on an arraywhich was suppressed with phlorizin, a specific inhibitor of the
sodium-dependent glucose transporters, and para-aminohip- of cell products, a newer approach to therapy, referred
purate (PAH) secretion, which was diminished with the anion to as cell therapy, is being actively pursued. Cell therapy
transport inhibitor probenecid. A variety of differentiated met- is based on cell and tissue culture techniques to expandabolic functions was also demonstrated in the RAD. Intralumi-
specific cells to perform differentiated tasks and to intro-nal glutathione breakdown and its constituent amino acid up-
duce these cells into the patient either in extracorporealtake were suppressed with the irreversible inhibitor of
circuits or as implants [2]. This approach harnesses the
natural ability of cells to recognize various biologicalKey words: epithelial transport, hemofiltration, kidney metabolism,
signals and to respond with a complex array of cell prod-renal tubule cells, renal failure, dialysis, cell therapy, ultrafiltration,
hollow fiber membrane. ucts for the replacement of physiological functions de-
ranged or lost in disease processes.Received for publication October 20, 1998
One extension of cell therapy is the developing fieldand in revised form December 31, 1998
Accepted for publication January 4, 1999 of tissue engineering in which techniques from the bio-
logical and engineering sciences are combined to create 1999 by the International Society of Nephrology
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structures and devices to replace tissue or organ physio- tubule has been reported with a confluent monolayer
along the inner surface of a hollow fiber and with provenlogical functions lost in acute and chronic disease [3].
The majority of current applications involve placing ani- functional transport properties [13]. The next step in
developing a bioartificial renal tubule assist devicemal or human cells within artificial constructs with cells
seeded into hollow-fiber bioreactors or encapsulating (RAD) as a cell therapeutic derivative to provide trans-
port, as well as metabolic and endocrinologic renal func-membranes. Pilot human studies have already been initi-
ated with extracorporeal liver-assist devices to replace tions, is to construct a multifiber hollow-fiber system. In
anticipation of this cell therapy approach adding valuehepatic function as a bridge to liver transplant in chronic
liver failure or regenerative recovery in acute hepatitis to the treatment of the large number of patients with
renal failure, a reliable tissue source to isolate renal[4]. Given the success of renal replacement therapy with
hemodialysis and hemofiltration during the last four de- tubule cells is required to meet the clinical demand.
For economic and safety concerns, the pig is currentlycades, a natural application of tissue engineering is in
the treatment of acute and chronic renal failure [5]. considered the best source of organs for both human
xenotransplantation and immunoisolation cell therapyAlthough current renal substitution therapy with he-
modialysis or hemofiltration has had a dramatic life- devices because of its anatomical and physiological simi-
larities to human tissue and the relative ease to breedsustaining effect in patients suffering from both acute or
chronic renal failure, these clinical disorders are still in large numbers [14, 15]. This report summarizes our
successful construction of a functional tissue-engineeredserious medical conditions [6, 7]. The average life expec-
tancy of a patient with end-stage renal disease (ESRD) bioartificial renal tubule system with porcine renal tubule
cells.once initiated on chronic hemodialysis is only four years.
The mortality rate of a patient with acute renal failure
(ARF) in the intensive care unit exceeds 50% [8]. This
METHODS
persistently poor prognosis of these disorders may be
Tissue source and cell isolationdue to the fact that hemodialysis and hemofiltration are
not complete renal replacement therapies. These tech- Pig kidneys were harvested from four- to six-week-
old Yorkshire breed pigs. Renal proximal tubule seg-niques provide only a clearance or filtration function
for small solutes but do not replace the lost transport, ments were harvested from the kidneys, and renal tubule
progenitor cells were selected and expanded with tech-metabolic and endocrine functions of the kidney, which
are predominantly found in the tubular elements of the niques previously described [10, 11].
organ. Accordingly, the development of renal tubule cell
Cell culturetherapy to replace these additional functions of the kid-
ney may add significant value to the currently suboptimal Cells were grown in 100 mm Corning culture dishes
with serum-free, hormonally defined Dulbecco’s modi-treatment of renal failure [9].
Critical to providing organ function replacement with fied Eagle’s (DME)-Ham’s F12 media containing 2 mm
glutamine and specific additives listed in Table 1. Oncecell therapy is the ability to isolate and grow in vitro
cells that possess stem cell-like characteristics with a high confluent, cells were processed for passage at a concen-
tration of 0.4 3 106 cells per ml as previously describedcapacity for self-renewal, and the ability to differentiate
into cells with correct structural and functional compo- [10, 11, 16]. Third- or fourth-passage cells were used for
various experimental studies. Preliminary experimentsnents to perform specialized physiological tasks. A meth-
odology to isolate and grow in tissue culture renal proxi- showed no difference between passages for transport
and metabolic characteristics.mal tubule progenitor cells from adult mammalian
kidneys has been recently achieved [10, 11]. In retro-
Renal tubule assist device design and fabricationspect, this finding is not surprising because renal proxi-
mal tubule cells have a resilient capacity for regeneration High-flux hemofiltration cartridges containing poly-
sulfone hollow fibers with surface areas of either 97 cm2after severe nephrotoxic and ischemic injury to reform
a fully functional and differentiated epithelium. (Fresenius AG, Bad Hamburg, Germany) with a molecu-
lar weight cut-off of 50,000 Da or 0.4 m2 (Minntech, Inc.,The bioartificial renal tubule can be constructed as a
combination of living cells supported on synthetic poly- Minneapolis, MN, USA) with a molecular weight cut-
off of 45,000 Da were used as scaffold devices (Fig. 1).meric hollow fibers, which are water and solute perme-
able. Using nonbiodegradable hollow-fiber membranes The smaller unit contained 128 polysulfone fibers with
an inner diameter of 200 mm, a wall thickness of 40 mm,with pore sizes, which exclude immunoglobulins and im-
munocompetent cells, immunoprotection of nonautolo- and a fiber length of 17 cm. The larger unit contained
4074 polysulfone fibers with an inner diameter of 250gous or xenogeneic cells can be achieved concurrent with
long-term functional performance [12]. The successful mm, a wall thickness of 70 mm, and a fiber length of 12.5
cm. The intraluminal surfaces of the hollow fibers inconstruction of a single hollow-fiber bioartificial renal
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Table 1. Cell culture medium for expansion of in Figure 2. Transmission electron microscopy demon-
porcine kidney renal tubule cells
strated that these cells possessed differentiated epithelial
DME Ham’s F12 with 2 mm glutamine plus cell characteristics, including apical microvilli, tight junc-
Insulin 5 ug/ml tional complexes, and endocytic vesicles (Fig. 3). TheTransferrin 5 ug/ml
evaluation of RAD units maintained under these incuba-Epidermal growth factor 60 ng/ml
Triidothyronine 6 pm tion conditions also demonstrated that confluent mono-
Hydrocortisone 0.1 um layers persisted within the fibers, as assessed by inulinRetinoic acid 0.1 um
leak rates, for as long as six months, the longest timeEthanolamine 0.5 um
Phosphorylethanolamine 0.5 um period that devices have been maintained. Functional
Prostaglandin E1 28 nm metabolic performance, as measured by ammonia pro-Dexamethasone 50 nm
duction, also persisted for this time frame.Selenite 29 nm
Sodium bicarbonate 14 nm
Trace elements Transport studies
MnCl2 * 4 H20 1 31026 mm
A known concentration of the test solute was addedNa2SiO3 * 9 H20 531024 mm
(NH4)6MO7O24 * 4 H20 131026 mm to the intraluminal perfusion solution. The perfusion
NiSO4 * 6 H20 5 31027 mm solution was infused into the intracapillary space of theSnCl2 * 2 H20 5 31027 mm
RAD at a rate of 5 ml/min. Tubing was connected toNH4VO3 531026 mm
Final solute concentrations one of the two ECS ports, as well as the intraluminal
Sodium 150 mEq/liter exit port and was drained into collection vials that werePotassium 4.4 mEq/liter
placed on a stand adjusted to the middle height of theChloride 137 mEq/liter
Bicarbonate 15.4 mEq/liter RAD. This setup allowed for quantitation of perfusate,
pH 7.25 reabsorbate, and collectate volume and solute concentra-Glucose 315 mg/dl
tions in a consistent manner. After 30 minutes of equili-
bration after initiating lumen perfusion, three to five
timed collections of reabsorbate and collectate from the
RAD were obtained and analyzed for both volume andthe cartridges were coated with pronectin-L (Protein
solute concentrations. Volume reabsorption and trans-Polymer, San Diego, CA, USA). Pronectin-L is a syn-
port rates were assessed from these direct measurements.thetic protein with multiple cell attachment sites found in
ECS volumes for the 97 cm2 and 0.4 m2 RADs were 7the extracellular protein laminin. Renal proximal tubule
and 85 ml, respectively. The ECS content was changedcells were then seeded at a density of 3 3 107 cells/ml
at the conclusion of each 30-minute interval by three
into the hollow fibers, with four cell infusions separated
volume changes of an albumin-containing media, there-
by 90 minutes and a 908 rotation of the cartridge. The by maintaining the albumin ECS fluid concentration. For
seeded cartridge was connected to a bioreactor perfusion all RADs, inulin leak rates were predetermined before
system in which the extracapillary space (ECS) was filled the experimental studies. Inulin (30 mg/dl) was added
with culture media and the intracapillary space was per- to the perfusate and infused at a rate of 5 ml/min. Three
fused with media at an initial rate of 2 ml/min for the 30-minute collections of the reabsorbate and collectate
97 cm2 unit or 4 ml/min for the 0.4 m2 unit. Perfusion were assessed for both volume and inulin concentration.
rates were then increased daily in increments of 0.4 ml/ Inulin levels were measured using a standard anthrone
min until final rates of 4 ml/min (97 cm2) or 6 ml/min colorimetric assay. The recovery of infused inulin in the
(0.4 m2) were achieved. Culture media, both intracapil- collectate was assessed and compared with the recovery
lary and extracapillary, were changed every two to three of inulin in the reabsorbate. An inulin loss rate as a
days to maintain adequate metabolic substrates for percentage of that infused was calculated using both of
growth and viability. Preliminary experiments demon- these measurements. The average inulin leak rates for
strated that at least 7 to 10 days of growth were necessary the 97 cm2 RAD and the 0.4 m2 RAD were 3.0 6 1.8
to reach confluency within the multiple fiber cartridge, and 5.7 6 3.5%, respectively. Only those RADs with an
as determined by inulin leak rates (described later in inulin leak rate of less than 5% for the smaller units and
this article). Accordingly, cell cartridges were used for less than 10% for the larger units were used for study.
study at least 14 days after seeding. The cell number in The inulin leak rate was used as a selection criteria to
RAD units was determined by lactate production, which ensure near confluency of the cells along the hollow
averaged 0.43 6 0.01 mmol/106 cells/24 hr. This resulted fibers within the unit. Bioreactors without cells had inulin
in an average cell number of 3.4 3 107 cells in each leak rates exceeding 40%. For all transport studies, bo-
97 cm2 RAD and 1.4 3 109 cells in each 0.4 m2 RAD. vine serum albumin (BSA) was added to the ECS at a
Histological examination of various RAD units demon- concentration of 2.5 g/dl. Unless otherwise stated, chemi-
cals were obtained from Sigma Chemical Co. (St. Louis,strated confluent monolayers of porcine cells, as depicted
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Fig. 1. Bioreactor hollow fiber cartridges
used as the scaffold components of the bioar-
tificial renal tubule assist devices tested for
these experiments. The upper and lower car-
tridges have surface areas of 97 cm2 and 0.4
m2, respectively. A 6 cm ruler is included in
the photograph to provide dimensional per-
spective of the devices.
Fig. 2. Light micrograph of a hematoxylin
and eosin stained section of a hollow fiber
with a confluent monolayer of porcine renal
proximal tubule cells along the inner surface
of the fiber. This particular fiber was 570 mm
in inner diameter. A larger diameter hollow
fiber than those used in RADs is depicted
here, since smaller fibers developed shear arti-
facts when processed for histology.
MO, USA). Electrolyte concentrations were measured of the RAD cartridges, the pH of both the perfusion
and ECS media was altered to varying pH levels (6.9 towith standard techniques. Inulin, glucose, and para-
aminohippurate (PAH) concentrations were assessed 7.5). Each cartridge was tested at a specific pH and then
allowed to equilibrate for two to three days under normalwith standard assays.
culture conditions before the next pH testing. Each RAD
Ammoniagenesis was tested at nine different pH settings on separate days
in a random sequence. Cartridges were incubated forPorcine proximal tubule cells were seeded and main-
tained in RAD cartridges. The cartridges were then eight 30-minute intervals. Media samples were collected
after each 30-minute incubation. The first 30-minute in-tested for ammonia production. To test pH responsivity
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Fig. 3. Electron micrograph of a confluent
monolayer of porcine renal proximal tubule
cells along the intraluminal surface of a RAD.
Differentiated epithelial characteristics are
easily identified, including microvilli, endo-
cytic vesicles, and extensive basolateral in-
foldings. Note that the larger gaps between
cells are indicative of intercellular infoldings.
The medium-sized openings located between
the nucleus and fiber membrane are composed
of a combination of mitochondria and endo-
cytic vesicles. The cells are supported on a
polysulfone membrane seen along the left
lower corner of the micrograph. Cellular via-
bility was demonstrated by a low inulin leak
rate and no lactate dehydrogenase (LDH) re-
lease.
cubation was not used in the data analysis. The ammonia hydroxyvitamin D3 (25-OHD3) was added to the media
at a final concentration of 10 nm. The culture plates wereconcentration was determined with a commercial kit
(Boehringer Mannheim, Indianapolis, IN, USA). placed on a shaking platform during incubation, and
media were collected after 5, 10, 15, 30, and 60 minutes
Conversion of 25-hydroxyvitamin D3 to following 25-OHD3 addition and were analyzed for 1,25-
1,25-dihydroxyvitamin D3 (OH)2-D3 levels. To confirm a similar conversion activity
in RAD units, the units were evaluated for 1,25-(OH)2-Cells were prepared as second or third passages.
Twenty-four hours prior to the study, the culture media D3 production rates by changing both the perfusion and
ECS media on the day of study to include 10 nm 25-were changed to one containing parathyroid hormone
(PTH; 1 ng/ml) and various levels of inorganic phosphate OHD3 with 1 ng/ml PTH and with 0.0 mm inorganic
phosphate to maximize conversion activity. After 24(0, 1, 3, or 6 mm). After this preincubation period, 25-
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Table 2. Fluid transport rates and tubular fluid/perfusion (TF/P) ratios in the RAD
Absolute Inulin TF/P ratios
reabsorption leak
Ouabain experiments ml/30 min percent Inulin Sodium Chloride
Baseline 1.0560.40 3.2560.21 1.0260.01 0.9960.02 1.0660.04
Albumin 4.8760.66a 3.1060.21 1.0460.01 1.0060.01 1.0860.04
Albumin 1 ouabain 1.7360.43b 2.9860.19 1.0460.01 0.9860.01 1.0760.05
N 5 4 for all conditions.
a P , 0.01
b P , 0.01 compared to albumin alone conditions
hours, both the perfusion and ECS fluids were assessed
for 1,25-(OH)2-D3 levels. PTH was obtained from Sigma
Chemical Co., and 25-OHD3 was from Upjohn Corp.
(Kalamazoo, MI, USA). 1,25-(OH)2-D3 levels were mea-
sured using a radioreceptor assay kit (Incstar Corp., Still-
water, MN, USA). The stock solution of 25-OHD3 was
formulated in 95% ethanol.
Statistical analysis
For experimental results, the number (N) of experi-
ments refers to the number of different RAD units used
for each experimental series. Because each experimental Fig. 4. Fractional fluid reabsorption of 97 cm2 RAD units (N 5 3)
maneuver obtained three to five separate measurements, under various conditions. After baseline measurements, bovine serum
albumin (2.5 g/dl) was added to the extracapillary space (ECS) toeach study with N units consisted of 3 3 N to 5 3 N
stimulate fluid transport with an oncotic pressure gradient. Ouabainspecific measurements for each experimental period. For (0.5 mm) was then added to the ECS in the presence of albumin to
statistical comparisons, either paired or nonpaired t-tests inhibit Na1,K1-ATPase activity.
were used. Values are expressed as mean 6 se.
RESULTS were not different from 1.0 during both periods, but the
Fluid reabsorption TF/P ratios for chloride were significantly greater than
1.0 (P , 0.05). To test the dependency of fluid transportA small osmotic pressure differential of two to three
in the RAD on Na1,K1-ATPase, ouabain (0.5 mm) wasmOsm/kg H2O is adequate to promote large isosmotic
added to the ECS in the presence of albumin. As summa-fluid transport due to the very high diffusive water per-
rized in Table 2 and Figure 4, significant (P , 0.01)meability of renal proximal tubule cells [17–19]. Fluid
declines in absolute and fractional reabsorption ratestransport across the proximal tubule epithelium is depen-
back to baseline levels were seen. This reduction ob-dent on both an osmotic pressure difference across the
served with ouabain averaged 64.6% of total volumeepithelium driven by active sodium transport and an
reabsorption rates in the presence of osmotic and oncoticoncotic pressure difference between the protein-free tu-
pressure differentials.bular fluid and the peritubular capillary system [17, 18].
To test the dependency of the fluid transport on oncotic
Bicarbonate transportpressure in the RAD, BSA was added to the ECS at a
Proximal tubule bicarbonate transport is an active pro-concentration of 2.5 g/dl. For all of these studies, RAD
cess dependent on proton secretion by the proximal tu-units with a surface area of 97 cm2 were used. As demon-
bule cell, titration of bicarbonate, and absorption of CO2strated in Table 2 and Figure 4, the change in oncotic
after dehydration of H2CO3 catalyzed by the apical mem-pressure increased absolute and fractional fluid reab-
brane-bound carbonic anhydrase [19, 20]. The fractionalsorption rates from baseline values of 1.05 6 0.4 ml/30
reabsorption rate of bicarbonate is greater than the frac-min and 0.82 6 0.3% to 4.87 6 0.66 and 3.87 6 0.43 ml/
tional rate of fluid reabsorption, resulting in a decline30 min (P , 0.01 and P , 0.001), respectively. Inulin
in pH axially along the proximal tubule [21]. For theserecovery rates did not change significantly between the
studies, larger RAD units (0.4 m2) were used to maximizetwo periods, whereas the collected tubule fluid to perfu-
transport ability, as demonstrated by the higher frac-sate (TF/P) concentration ratio for inulin increased from
1.02 6 0.01 to 1.04 6 0.1. The ratios of TF/P for sodium tional reabsorption rate and TF/P inulin ratios summa-
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Fig. 5. Fractional bicarbonate reabsorption rates in 0.4 m2 RADs (N 5 Fig. 6. Fractional glucose reabsorption in 0.4 m2 RAD units (N 5
3) under baseline and acetazolamide conditions. After baseline mea- 5) under baseline and phlorizin exposure conditions. After baseline
surements, acetazolamide (100 mm), a specific carbonic anhydrase inhibi- measurements, phlorizin was added to the luminal perfusion fluid and
tor, significantly diminished bicarbonate transport in the RAD (*P , the ECS medium at various concentrations (2.5 to 7.5 mm) as a specific
0.01). inhibitor of glucose transporters. A significant dose-related decline in
glucose reabsorption was observed in comparison to baseline conditions
(*P , 0.05; *P , 0.001).
Table 3. Bicarbonate transport in the RAD
Absolute Fractional TF/P ratios Glucose transportreabsorption reabsorption
Condition mEq/30 min % Inulin Bicarbonate Proximal tubule glucose transport is also an active
Baseline 0.4460.04 20.4 62.0 1.10 60.02 0.71 60.02 transport process. The process has evolved to be very
Acetazolamide 0.1360.01a 4.160.5a 1.1060.03 0.87 60.02a efficient so that under normal plasma glucose levels, the
N 5 3 for each condition. Values are expressed as mean 6 SE. Abbreviation amount of filtered glucose presented to the proximal
TF/P is tubular fluid/perfusion.
tubule in vivo is nearly completely reclaimed by the enda P , 0.01 compared to baseline values
of this nephron segment [22, 23]. The glucose transport-
ers in the renal epithelium are specifically inhibited by
the compound phlorizin [24]. For all studies, 0.4 m2 RAD
rized in Figure 5 and Table 3. Under baseline conditions, units were used. As demonstrated in Figure 6, the units
with a perfusion and ECS media with pH 7.23, pCO2 38 had a fractional reabsorption rate of 25.0 6 1.2% with
mm Hg, and bicarbonate 15.4 mm, bicarbonate reabsorp- a (TF/P) ratio of 0.83 6 0.4 (N 5 7) and a corresponding
tion rate of the RAD averaged 0.44 6 0.04 mEq/30 min absolute rate of glucose transport of 37.8 6 2.4 mg/30
and a fractional reabsorption rate of 21.9 6 1.8% (N 5 min (N 5 7). Phlorizin addition to the luminal perfusion
3). This rate resulted in a TF/P ratio for bicarbonate of fluid and to the ECS medium significantly inhibited glu-
0.71 6 0.02 (N 5 3), with a post-RAD luminal bicarbon- cose transport in the RAD in a dose-dependent fashion
ate concentration on average of 11.0 mEq/liter compared (Fig. 6). Accordingly, ratios for (TF/P) glucose increased
with 15.4 mEq/liter in the perfusate. This resulted in an from a baseline of 0.83 6 0.04 to 0.85 6 0.04, 0.88 6
average pH change of 7.23 in the perfusate to 7.08 in 0.03, and 0.96 6 0.03 with phlorizin concentrations of
the collectate. The dependence of the RAD bicarbonate 2.5, 5.0, and 7.5 mm, respectively (N 5 2 to 7 for each
transport process on carbonic anhydrase was tested with condition). Phlorizin was then removed from the unit
the addition of acetazolamide (100 mm), a specific inhibi- with 3 3 flush, at which time further assessments were
tor of carbonic anhydrase, into the perfusate and the determined showing a return to baseline levels for glu-
ECS. This addition resulted in a significant fall in the cose transport. The phlorizin-suppressible fraction ap-
absolute rate of bicarbonate transport from 0.44 6 0.04 proximates the minimal transepithelial transport rate for
mEq/30 min to 0.13 6 0.01 mEq/30 min (N 5 3, P , glucose.
0.01) and a decline of fractional reabsorption from 21.9 6
Para-aminohippurate transport1.8% to 4.1 6 0.5%. The collectate bicarbonate concen-
tration and pH returned to near baseline levels of 12.8 6 Para-aminohippurate (PAH) is considered a proto-
0.2 mEq/liter and 7.15, respectively. After completion of typic organic anion and has been commonly used to
acetazolamide studies, ECS and lumen were rinsed with examine renal transport properties because it is mini-
a 3 3 volume flush, at which time bicarbonate transport mally protein bound, is not metabolized, and is actively
was reassessed and shown to return to baseline levels secreted by the renal proximal tubule [25]. To test the
ability of the RAD to secrete PAH, larger RAD units(data not shown).
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Fig. 7. Influence of probenecid on para-aminohippurate (PAH) secre-
tion in 0.4 m2 RAD units (N 5 3). Probenecid (5 mm) addition to the
Fig. 8. Fractional rates of glutathione degradation and removal fromextracapillary space (ECS) significantly inhibited the PAH secretion
the luminal perfusate in 97 cm2 RADs (N 5 5) were assessed underrate from ECS to luminal spaces in these units (*P , 0.05).
baseline conditions. After baseline measurements, acivicin (1 mm) was
added to the perfusion fluid as a specific inhibitor of g-glutamyl trans-
peptidase, an enzyme responsible for glutathione breakdown along
the brush border membrane. This addition significantly inhibited the
removal rate of glutathione from the perfusate (*P , 0.05).(0.4 m2) were placed in a perfusion circuit with no PAH
in the luminal perfusate and 10 mg/ml PAH in the ECS.
At a luminal perfusion rate of 5 ml/min, PAH secretion
from ECS to tubular fluid was 3.4 6 0.1 mg/2 hr (N 5
the perfusate to 25 6 4% (P , 0.05) and an increase3) and resulted in a post-RAD tubular fluid PAH concen-
in TF/P to 0.75 6 0.04. Because the delivery rate of
tration of 0.66 6 0.02 mg/dl. Probenecid is a recognized
glutathione to the RAD averaged 83 6 13 nmol/min,
inhibitor of proximal tubule PAH secretion [26]. After
this degradation rate was determined to be 1.57 6 0.3
baseline PAH transport rates were determined, probene- nmol/106 cells/min.
cid (5 mm) was added to the ECS space. As depicted in
Figure 7, probenecid decreased PAH secretion from Ammoniagenesis
3.4 6 0.1 to 2.1 6 0.2 mg/2 hr (P , 0.0001). This decline The ability to produce and excrete ammonia is essen-
resulted in a 38% reduction in PAH secretion with the tial for the kidneys to eliminate an acid load and to
addition of probenecid. The post-RAD tubular fluid maintain acid-base homeostasis in the body. Although
PAH concentration decreased from 0.66 6 0.02 to 0.41 6 all nephron segments produce ammonia, the proximal
0.02 mg/dl (P , 0.0001) with probenecid. Parallel control tubule is the source of the majority of ammonia produc-
studies without probenecid were performed demonstra- tion of the kidney. Because a key role for renal ammonia
ting no change in PAH secretion over time. production is to excrete an acid load by acting as a tubu-
lar fluid buffer for proton secretion and excretion, theGlutathione transport and metabolism
proximal tubule cell has developed an ability to respond
Glutathione is a tripeptide (g-glutamylcysternylgly- rapidly and sensitively to enhance ammoniagenesis with
cine) and is freely filtered by the glomerulus. The proxi- acute declines in pH both in vitro and in vivo [29, 30].
mal tubule reclaims the filtered glutathione by a process As demonstrated in Figure 9, proximal tubule cells in
of degradation and transport of its constituent amino 97 cm2 RAD units (N 5 4) demonstrated incremental
acids from the luminal space [27]. The initial reaction in increases in ammonia production in response to pH
the degradation of glutathione is catalyzed by g-glut- changes in the incubation media from 7.50 to 6.90 to a
amyltranspeptidase, which is bound to the brush bor- level as high as 15 mg/106 cells/30 min. Although baseline
der membrane. The selective irreversible inhibitor of NH3 production rates at pH 7.4 and 7.5 levels were simi-
g-glutamyltranspeptidase, acivicin, has been shown in lar between cells grown on 100 cm2 culture plates and
vivo to inhibit almost completely the removal of glutathi- cells in the RADs, the ammonia production rates were
one from the tubular lumen [28]. For these studies, 97 three times higher in the RADs compared with cells
cm2 RAD units were used. As demonstrated in Figure grown on 100 cm2 culture plates when the pH was
8, the removal of glutathione from the perfusion fluid changed to 7.1 and 7.0 (data not shown).
entering the RAD units (N 5 5) averaged 44 6 2%,
Vitamin D activationwith a TF/P ratio of 0.56 6 0.02. The addition of 1 mm
acivicin to the perfusion fluid significantly inhibited the The most active form of vitamin D is 1,25-(OH)2D3.
removal of glutathione from the tubular lumen, with a The kidney is the major site of production of this active
metabolite [31]. The renal enzyme responsible for thedecrease in the percentage of glutathione removed from
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Fig. 11. Rate of 1,25-(OH)2D3 production from 25-OH-D3 in renal
proximal tubule cells on culture plates was measured with two inorganic
phosphate (Pi) levels in the media in the presence (j) or absence (h)Fig. 9. Influence of altering the pH of the perfusion and extracapillary
of parathyroid hormone (PTH; 1 ng/ml). PTH significantly increasedculture media on the rate of ammonia production in 97 cm2 RAD units
production rates in the presence of 0.0 (P , 0.001) and 3.0 mm (P ,(N 5 4). Decreases in pH enhanced ammoniagenesis in these devices.
0.01) Pi concentrations.
DISCUSSION
The results of these experiments provide significant
steps in the development of a bioartificial RAD to im-
prove renal replacement therapy. This device, as demon-
strated in these studies, provides differentiated transport
and metabolic and endocrine functions of the kidney.
Thus, when placed in series with a conventional artificial
hemofilter, it can optimize renal substitution therapy
from the clearance of small solutes currently achieved
with hemodialysis or hemofiltration to a full array of
differentiated renal functions. A recent report from our
Fig. 10. Rate of 1,25(OH)2 vitamin D3 production from 25-OH vitamin laboratory demonstrated successful construction of a sin-
D3 by renal proximal tubule cells on culture plates with varying inorganic gle hollow-fiber bioartificial renal tubule using Madin-phosphate (Pi) levels in the culture media and increasing incubation
Darby canine kidney (MDCK) cells, a permanent renaltimes. Incremental declines in conversion rate with increasing Pi concen-
trations were observed. Symbols are: (h) 0.0 mm Pi; (j) 1.0 mm Pi; ( ) epithelial cell line [13]. The cells within this single bioar-
3.0 mm Pi; ( ) 6.0 mm Pi. tificial renal tubule construct grew as a confluent mono-
layer along the inner aspects of the hollow fiber, as dem-
onstrated both histologically and functionally with a
greater than 99% recovery rate of infused inulin. Thisconversion of 25-OH-D3 to 1,25-(OH)2D3 is the 25- single bioartificial tubule also was shown to perform ac-(OH)D3-12-hydroxylase enzyme, which is a cytochrome tive fluid reabsorption, which was dependent on Na1,K1-
P-450 monooxygenase located along the inner mitochon-
ATPase.
drial membrane of proximal tubule cells [32]. The activity From this initial success, the results reported here are
of this enzyme is regulated by a number of factors but, critical next steps in the development of a bioartificial
most importantly, is stimulated both by PTH and by low renal tubule device to progress to large animal experi-
inorganic phosphate (Pi) concentrations [33]. As dis- ments and human clinical trials. To scale up a multifiber
played in Figure 10, cells on culture plates were able to bioreactor, cells isolated from a fresh tissue source rather
convert 25-OH-D3 to 1,25-(OH)2D3 at a rate as high as than cells from a permanent cell line were chosen. The
32.4 6 21 fmol/106 cells/hr or 13.5 6 0.9 pg/106 cells/hr. rationale for this choice is reflective of the basic premise
This conversion rate was up-regulated in the presence of cell therapy that differentiated cells, rather than undif-
of PTH and down-regulated with an increase in Pi in the ferentiated transformed cells, are best suited to replace
culture medium (Figs. 10 and 11). This enzyme activity metabolic and physiologic functions deranged or lost
was also demonstrated in 97 cm2 RAD units in which in a disease process [2]. Differentiated cells, with their
1,25-(OH)2D3 production rates averaged 8.8 6 2.6 fmol/ natural ability to recognize a large array of biological
106 cells/hr in three RAD units in the presence of PTH signals, are best able to respond with a range of cell
mediators in clinical disorders. Differentiated cells thusand 0 mm Pi.
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act as drug-delivery vehicles to deliver a number of cell Less than 60% of the perfused inulin was recovered in
the postlumen collectate of noncell units preadheredproducts, many of which may have yet to be identified
or appreciated as instrumental in modulating or sup- with pronectin L, whereas cell containing units had a 95
to 97% recovery rate. Evaluation of these RAD unitspressing a disease process. This cellular response to a
clinical disorder provides a higher likelihood to affect a demonstrated persistent monolayer confluency and met-
abolic activity for as long as six months after initial devicedisease process favorably in contrast to a single com-
pound as a therapeutic treatment for a complex and construction, the maximal time period of performance
assessment in this series of experiments. Stacking andevolving clinical disease process. Accordingly, the use of
a transformed permanent cell line provides a lesser de- overgrowth of epithelial cells within the fiber lumens
were not observed (several hundred fibers from multiplegree of differentiated cellular response to the variety of
biological signals, which may be critical in altering a cartridges were examined). The number of cells within
a 0.4 m2 cartridge was determined to average 1.4 3 109disease state.
In order to obtain cells from a tissue source to con- cells. This number compares favorably for the proximal
tubule cell mass within a mammalian kidney. A proximalstruct physiological replacement devices, a methodology
to select cells that have a high capacity for self-renewal tubule is approximately 10 mm long, with an outer diam-
eter of 50 mm. Assuming a tubule cell as a cube withand the ability to differentiate under defined growth
conditions must be developed. Recent data from our an edge of 20 mm, a single proximal tubule consists of
approximately 5000 cells. With 1 3 106 nephrons in alaboratory have identified methods to isolate and grow
renal proximal tubule progenitor cells from adult mam- kidney, the proximal tubule cell mass in a kidney is
approximately 5 3 109 cells.malian kidneys [10, 11] as an important step in the con-
struction of a bioartificial renal tubule system. The deci- The attainment of proper differentiated structural
characteristics of these cells within the RAD led to asion to use porcine renal tubule cells was based on the
reliability of the tissue source and the physiological simi- series of functional assessments of differentiated proxi-
mal tubular processes. The initial experiments were de-larities of porcine tissue to human tissue [14, 15]. A
serum-free, hormonally-defined cell culture medium was signed to test transport characteristics of the RAD, using
a single-pass perfusion system. The proximal tubule indeveloped, as detailed in Table 1, to optimize porcine
renal proximal tubule cell growth. vivo reabsorbs 50 to 60% of the solutes and water filtered
at the glomerulus. Tubular fluid reabsorption is iso-The design and fabrication of a multifiber RAD were
made easier with the commercial development of car- osmotic and is driven by both osmotic and oncotic pres-
sure differences across the renal proximal tubule epithe-tridges containing biocompatible polysulfone hollow-
fiber membranes with varying surface areas, with high lium [17]. The addition of albumin to the ECS of the
RAD resulted in a significant increase in fluid reabsorp-water permeability and with molecular weight cut-offs
between 45,000 and 50,000 Da, pore sizes that are immu- tion with a rise in the TF/P inulin ratio proportionate to
the increase in fractional fluid reabsorption. This obser-noisolating [12]. Using these cartridges as scaffold de-
vices, preliminary experiments were undertaken to opti- vation directly confirms the important role of peritubular
protein concentration on proximal tubule fluid transfer.mize the attachment and growth of these cells to the
inner walls of the polymeric fibers. Various extracellular An osmotic pressure difference across the renal epithe-
lium also promotes isotonic fluid transport [18]. Thismatrix molecules were assessed, including collagen type
I, collagen type IV, fibronectin, and laminin. Laminin, a osmotic gradient across the monolayer is maintained by
active Na1 transport driven by the energy requiringmajor constituent of the renal tubular basement mem-
brane, was found best able to support attachment and Na1,K1-ATPase. To test the dependency of fluid reab-
sorption on this process in the RAD, ouabain, a specificgrowth of these cells along the inner surface of the hollow
fibers [34]. Thus, a synthetic derivative of laminin, inhibitor of Na1,K1-ATPase, was added to the ECS in
the presence of albumin. A significant decline in fluidpronectin-L, was used as a key component for the con-
struction of this device. Once seeded and attached, the transport occurred after ouabain administration, thereby
demonstrating the dependency of this fluid flux on activecells along the hollow fibers also required carefully con-
trolled increases in the perfusion rate in order for them Na1 transport.
The absolute reabsorption rate observed in the 97 cm2to adapt to incremental shear forces and to minimize
detachment from the scaffold. Finally, a seeding density RAD under these in vitro conditions averaged 4.5 ml
per 30 minutes, resulting in a calculated water permeabil-of cells to maximize initial attachment was identified.
Using this carefully determined fabrication methodol- ity of 2.7 3 1025 cm/second, a value substantially lower
than reported values in mammalian proximal tubules (asogy, consistent monolayer growth along the membrane
surfaces was achieved within 14 days after cell seeding. low as 0.07 and as high as 0.7 cm/second) [19], but similar
to that reported for the single bioartificial tubule usingSuccessful confluent growth of these cells was demon-
strated by the low inulin leak rates in the RAD units. MDCK cells and other natural transporting epithelia [13,
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35]. This major difference could be due to a variety of The observed RAD transport rate is most likely an un-
derestimate of the maximal rate achievable, because thedifferences between the bioartificial RAD and the natu-
ral proximal tubule, such as unstirred layers and surface perfusate glucose concentration was not varied to assess
Tm values of the units.area to volume relationships. With this flux rate, the
surface area required to reabsorb 50% of a clinically In addition to reabsorptive transport processes, the
kidney has important secretory pathways to transportachievable 15 ml/min hemofiltration rate would be ap-
proximately 1.0 m2, a surface area compatible for the compounds from the peritubular environment into the
tubular lumen [25]. A large variety of endogenous or-clinical use of an extracorporeal or implantable device.
The transport of solutes from the lumen of the proxi- ganic anions and xenobiotics are required to be excreted
by the kidney via secretory processes to avoid potentiallymal tubule is also characterized by active transport pro-
cesses to reclaim essential nutrients, such as glucose and toxic accumulation. PAH has been a classic organic anion
to assess these secretory transport activities of the proxi-amino acids, as well as sodium bicarbonate [36]. This
process results in the decline in the TF/P ratios of these mal tubule. PAH addition to the ECS of RAD units
resulted in significant secretion rates of approximatelysubstances. This preferential reabsorption of bicarbon-
ate with sodium results in an increase of TF/P chloride 30 mg/min. Converting this rate for proximal tubule cell
mass in the mammalian kidney results in a transportratios above 1.0 along the proximal tubule. In a similar
manner, an increase in TF/P chloride ratio and a decline capacity of less than 1 mg/min compared with a maximal
PAH transport rate of 77.5 mg/min in humans [36]. Thein TF/P bicarbonate ratio were, in fact, observed as the
luminal perfusate exited the RAD. The average decline organic anion transporter in the kidney responsible for
PAH and other important organic compounds, such asfor TF/P bicarbonate reached an average of 0.71 6 0.02,
a value in excess of the 0.3 to 0.4 ratios observed in salicylate and a-ketoglutarate, is specifically inhibited by
the agent probenecid [26]. This compound had a signifi-proximal tubule microperfusion experiments [20, 21],
suggesting that bicarbonate transport in the RAD is not cant effect to diminish PAH secretion in the RAD units.
The proximal tubule and kidney not only possess keyas efficient as the natural occurring process in the proxi-
mal tubule. This difference in efficiency was also demon- transport functions for excretory processes but also pro-
vide critical metabolic and endocrinological functions.strated with the observation that the post-RAD luminal
fluid achieved a bicarbonate concentration of 11.0 mEq/ In this regard, the kidney plays an integral role in gluta-
thione metabolism of the body [27]. Glutathione is theliter and a pH of 7.08 compared with values of 8.0 mEq/
liter and 6.7 in micropuncture assessments in vivo [21]. most abundant intracellular peptide and thiol. Its role
as an antioxidant is critical in host defense, tissue injury,The bicarbonate reclamation process along the proximal
tubule is dependent on the enzyme carbonic anhydrase, and cell viability. The initial step in glutathione metabo-
lism is its release from the cell into the plasma, wherewhich catalyzes the conversion of H2CO3 to H2O and
CO2 [20]. The dependence of bicarbonate transport in it is presented to kidney and freely filtered at the glomer-
ulus into the tubular lumen. The reclamation of thisthe RAD on this process was clearly demonstrated by
a significant decline in bicarbonate transport after the important compound occurs mainly in the proximal tu-
bule by a process of degradation and transport of itsaddition of acetazolamide, a specific carbonic anhydrase
inhibitor, to the RAD. constituent amino acids [27]. Once within epithelial cells,
glutathione is resynthesized and returned to the systemicThe active reclamation of luminal glucose in the RAD
was also demonstrated in these experiments with a de- circulation to maintain plasma levels within normal lim-
its. This reclamation process was clearly demonstratedcline in TF/P ratios for glucose to 0.82 6 0.4. Glucose
transport in the proximal tubule occurs via sodium- in the RAD, with almost 50% of the glutathione entering
the RAD being removed in a single pass. This rate ofdependent glucose transporters, which are specifically
inhibited by the compound phlorizin [24]. The evidence removal compares favorably to the 80% reclamation rate
observed in the isolated perfused kidney [37]. This re-that phlorizin inhibits, in a dose-dependent manner, the
glucose transport in the RAD units confirms that these moval process for glutathione was due to the degradation
and transport of its amino acids by the demonstrationsodium-dependent glucose transporters are responsible
for this reabsorption process. The rate of glucose recla- that acivicin substantially blocked glutathione removal
rate from the tubular lumens. Acivicin is a selective andmation in the 97 cm2 RAD averaged slightly greater
than 1 mg/min. The normal mammalian kidney almost irreversible inhibitor of g-glutamyltranspeptidase, the
brush border-bound enzyme responsible for the initialcompletely reclaimed all filtered glucose to a tubular
maximum (Tm) of 400 mg/min [22]. Because a 97 cm2 degradation of glutathione within the kidney [28].
Another key metabolic function of the kidney is am-RAD has 3.4 3 107 proximal tubule cells compared with
the 5 3 109 cells in the mammalian kidney, a comparably moniagenesis. The renal production of ammonia is essen-
tial for the elimination of an acid load and maintenancesized RAD device could transport up to 150 mg/min, a
value still below that of the naturally occurring kidney. of acid-base balance in the body. The proximal tubule
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is the predominant site for kidney ammonia production the cells in the RAD units, on the other hand, demon-
[29]. Ammoniagenesis in the kidney and proximal tubule strated levels of activity nearly equivalent in magnitude
cells is enhanced with acute declines of pH within the to whole kidney function in vivo when corrected for
physiological range to aid in the excretion of an acid load equivalent whole kidney proximal tubule cell mass. It is,
[30]. The RAD units in this study clearly demonstrated a in fact, these metabolic and endocrinological functions
high capacity for ammonia production that was respon- that may provide the added value of this device in the
sive to pH variations. In fact, at pH 6.90, the RAD units clinical situation. Experiments in uremic dogs with ARF
produced 15 mg/106 cells/30 min or a rate of 15 to 20 have recently shown the ability of the RAD to maintain
mmol/min for an equivalent proximal tubule cell mass viability in a uremic environment when placed in series
in a kidney. This level of production compares favorably with a conventional hemofilter and an extracorporeal
to the rate observed in dog kidneys in vivo and rat kid- blood circuit [40]. These experiments also demonstrated
neys in vitro of approximately 20 and 0.3 mmol/min, the retention of active transport, and metabolic and en-
respectively [29, 30]. docrinologic functions of the RAD ex vivo similar to the
The final differentiated renal tubule function tested in vitro renal functions summarized in this report.
with the RAD units was endocrinological conversion of The success of these experiments in acutely uremic
25-OH-D3 to 1,25-(OH)2D3, the most active form of this large animals allows the prospect of the initial clinical
important hormone [33]. These experiments demon- use of this device in patients with acute tubular necrosis
strated that proximal tubule cells in cell culture and in who require renal substitution therapy in the intensive
the RAD units were able to produce 1,25-(OH)2-D3 at care unit. As currently planned, the RAD will be placed
rates of greater than 10 and 3.5 pg/106 cells/hr, respec- in a standard extracorporeal blood perfusion circuit in
tively, which are comparable when adjusted for cell mass series with a conventional hemofilter. The ultrafiltrate
to rates of 100 to 500 pg/hr observed in rats in vivo [38]. formed from the hemofilter will be delivered into the
Further data revealed that the cells and RAD cartridges luminal compartment of the RAD. The filtered blood
regulated this conversion rate in response to PTH and exiting the hemofilter will then be delivered to one of
inorganic phosphorus levels, key regulatory factors for the two extracapillary ports of the RAD. Upon its exit
vitamin D activation in vivo. from the second ECS port, the post-RAD blood is deliv-
The data summarized in this report clearly demon- ered back to the treated individual. The processed ultra-
strate the successful tissue engineering construction of filtrate exiting the luminal compartment of the RAD
a bioartificial RAD, which effectively performs critical will be discarded as “urine.” This set-up replicates the
differentiated transport that includes enhancing the met- structural anatomy of the nephron and allows the tubule
abolic and endocrinologic functions of the kidney. Start-
cells to return transported and metabolized compounds
ing from an inanimate polymeric hollow-fiber mem-
from the ultrafiltrate or blood back to the patient. Thisbrane, the successful growth of epithelial cells along this
device may be used in patients with ESRD in a similarmembrane surface converted this passive membrane into
manner, but will appropriately await the results of thea living semipermeable membrane with exquisite selec-
RAD in acute interventions to gain an appreciation oftive properties responsive to proper physiological cues.
the additional difficulties that may occur with the chronicThe successful construction of this bioartificial tubule
use of such a device.system is remarkable in light of the extensive manipula-
Although current renal substitution therapy with he-tion of these cells from the original tissue with subse-
modialysis or hemofiltration is life sustaining in patientsquent tissue culture growth under selective conditions,
with both acute or chronic renal failure, it is still subopti-and final seeding and expansion into a device cartridge
mal with high rates of morbidity and mortality. The addi-to a cell mass equivalent of several billion cells. These
tion of these key tubular functions with the RAD willresults demonstrated that the tissue-engineered con-
substitute critical processes currently lacking with dia-struct possesses differentiated reabsorption and secre-
lytic devices. These metabolic and endocrinologic func-tory transport capabilities that were due to specific active
tions will not only provide almost complete renal re-transporters found in the proximal tubule cell in vivo.
placement therapy, but also therapy that is responsive toThese transport functions, however, fell short in effi-
naturally evolved physiological parameters. The recentciency when compared with transport activity found in
successful completion of large animal studies sets thethe natural occurring proximal tubule. This inefficiency
stage for initial pilot human clinical studies to proceedpoints to areas to focus further improvement of this
in the near future.tissue-engineered device. Evaluation of smaller diameter
hollow fibers and improved flow characteristics within
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